Exact Mass: 1092.4717468000001

Exact Mass Matches: 1092.4717468000001

Found 14 metabolites which its exact mass value is equals to given mass value 1092.4717468000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Premithramycin B

Premithramycin B

C53H72O24 (1092.4413)


   

Prechromomycin B

Prechromomycin B

C53H72O24 (1092.4413)


   
   

(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one 3-O-2)-O-3)>-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-galactopyranoside>|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one3-O-{O-beta-D-glucopyranosyl-(1[*]2)-O-[beta-D-glucopyranosyl-(1[*]3)]-O-beta-D-glucopyranosyl-(1[*]4)-beta-D-galactopyranoside}

(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one 3-O-2)-O-3)>-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-galactopyranoside>|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one3-O-{O-beta-D-glucopyranosyl-(1[*]2)-O-[beta-D-glucopyranosyl-(1[*]3)]-O-beta-D-glucopyranosyl-(1[*]4)-beta-D-galactopyranoside}

C51H80O25 (1092.4988)


   

G Protein Antagonist

G Protein Antagonist

C57H64N12O9S (1092.464)


   

Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 trifluoroacetate salt

Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 trifluoroacetate salt

C49H68N14O15 (1092.4988)


   
   
   
   

KSPWFTTL (TFA)

KSPWFTTL (TFA)

C50H71F3N10O14 (1092.5103)


KSPWFTTL TFA is an immunodominant Kb-restricted epitope from the p15E transmembrane protein. KSPWFTTL TFA can restore susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes[1][2].

   

n-[15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-2-(1-hydroxyethyl)-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-{[1,2-dihydroxy-3-(sulfooxy)propylidene]amino}-3-(4-hydroxyphenyl)propanimidic acid

n-[15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-2-(1-hydroxyethyl)-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-{[1,2-dihydroxy-3-(sulfooxy)propylidene]amino}-3-(4-hydroxyphenyl)propanimidic acid

C47H68N10O18S (1092.4434)


   

(1's,2r,2's,4's,5r,7's,8'r,9's,13's,15'r,16'r,18's)-16'-{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-5-{[(2s,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl]oxy}-15'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one

(1's,2r,2's,4's,5r,7's,8'r,9's,13's,15'r,16'r,18's)-16'-{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-5-{[(2s,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl]oxy}-15'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one

C51H80O25 (1092.4988)


   

16'-[(3,4-dihydroxy-5-{[5-hydroxy-6-(hydroxymethyl)-3,4-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl)oxy]-15'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one

16'-[(3,4-dihydroxy-5-{[5-hydroxy-6-(hydroxymethyl)-3,4-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-2-yl)oxy]-15'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one

C51H80O25 (1092.4988)


   

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-8-[(2r)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-2-[(1r)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-{[(2r)-1,2-dihydroxy-3-(sulfooxy)propylidene]amino}-3-(4-hydroxyphenyl)propanimidic acid

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-8-[(2r)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-2-[(1r)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-{[(2r)-1,2-dihydroxy-3-(sulfooxy)propylidene]amino}-3-(4-hydroxyphenyl)propanimidic acid

C47H68N10O18S (1092.4434)